Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
Cell Metabolism
|
November 26, 2019
STAT3 Activation-Induced Fatty Acid Oxidation in CD8<sup>+</sup> T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth
Chunyan Zhang, Chanyu Yue, Andreas Herrmann, et al.
The Oncologist
|
November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
The Journal of Clinical Investigation
|
April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signaling
Qiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
JCI Insight
|
August 30, 2019
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A Egelston, Christian Avalos, Travis Y Tu, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Blood
|
March 22, 2022
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE
Matthew G Mei, Hun Ju Lee, Joycelynne M Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2016
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR
Daniel J Munson, Colt A Egelston, Kami E Chiotti, et al.
Journal of Translational Medicine
|
March 29, 2011
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
Paolo A Ascierto, Eleonora De Maio, Stefano Bertuzzi, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Journal of Proteomics
|
January 15, 2018
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection
Dmitri V Rozanov, Nikita D Rozanov, Kami E Chiotti, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
Cell Metabolism
|
November 26, 2019
STAT3 Activation-Induced Fatty Acid Oxidation in CD8<sup>+</sup> T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth
Chunyan Zhang, Chanyu Yue, Andreas Herrmann, et al.
The Oncologist
|
November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
The Journal of Clinical Investigation
|
April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signaling
Qiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
JCI Insight
|
August 30, 2019
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
Colt A Egelston, Christian Avalos, Travis Y Tu, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Blood
|
March 22, 2022
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE
Matthew G Mei, Hun Ju Lee, Joycelynne M Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2016
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR
Daniel J Munson, Colt A Egelston, Kami E Chiotti, et al.
Journal of Translational Medicine
|
March 29, 2011
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"
Paolo A Ascierto, Eleonora De Maio, Stefano Bertuzzi, et al.
Nature Medicine
|
June 28, 2024
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, et al.
Journal of Proteomics
|
January 15, 2018
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection
Dmitri V Rozanov, Nikita D Rozanov, Kami E Chiotti, et al.
Page
of 13